Details for Patent: 6,197,341

Summary for Patent: 6,197,341

Title:	Formulations of balsalazide and its derivatives
Abstract:	The invention provides a unit formulation which comprises a 2-hydroxy-5-phenylazobenzoic acid derivative which is particularly sodium balsalazide dihydrate which formulation has a density of at least 0.9 mg/mm.sup.3 and its use in the treatment of gastrointestinal diseases.
Inventor(s):	Friess; Stefan (S-22587 Hamburg, DE), Heckenmuller; Harald (D-22559 Hamburg, DE), Szambien; Oliver (D-23611 Bad Schwartau, DE)
Assignee:
Application Number:	09/068,823
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,197,341
Patent Claim Types: see list of patent claims	Formulation; Compound; Composition; Dosage form; Use;

Drugs Protected by US Patent 6,197,341

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 6,197,341

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Sweden	9700934-4	Mar 14, 1997

International Family Members for US Patent 6,197,341

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	6430198
Belgium	1011837
Brazil	9808140
Canada	2283297
European Patent Office	1003524
France	2760638
Greece	980100096